Chemical formula: C₂₀H₂₆N₂O₄ Molecular mass: 358.431 g/mol PubChem compound: 3792
Itopride activates the gastrointestinal propulsive motility by dopamine D2 receptors antagonistic action and acetylcholine esterase inhibitory action. Itopride activates acetylcholine release and inhibits its degradation.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A03FA07 | A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03F Propulsives → A03FA Propulsives | |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| PROGIT Film-coated tablet | MPI, EU: SmPC | ||
| TOPRISAN Film-coated tablet | Medicines Authority (MT) | MPI, EU: SmPC |
Itopride is an active ingredient of these brands:
Croatia (HR)
Cyprus (CY)
Ecuador (EC)
Japan (JP)
Lithuania (LT)Malta (MT)
Mexico (MX)
Nigeria (NG)
Romania (RO)
Turkey (TR)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
